A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxide. - Wikidata - awgldk - TriplyDB

A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxide.

A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxide.

http://www.wikidata.org/entity/Q35019853

about

Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals.Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model.The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseases.A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.Oxidative Stress and Cardiovascular Aging: Interaction Between NRF-2 and ADMA.Investigations of possible prodrug structures for 2-(2-mercaptophenyl)tetrahydropyrimidines: reductive conversion from anti-HIV agents with pyrimidobenzothiazine and isothiazolopyrimidine scaffolds.Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease.

P2860

Q26771754-303F8A53-73B4-4B87-A252-B35683D5EF00 Q28070134-7FDC415E-DA30-420E-9575-49F6655BE9F3 Q35625951-31BDF00D-6B4F-4FED-833B-2BB58F10E784 Q37607150-ACD9DF6C-84C4-4A11-AD09-A941862A028B Q38203518-3F8DCAED-8BC4-43EE-B6A3-DA91041F7184 Q38652256-33C78286-B2B9-4A8D-8605-4770E1E97AC6 Q39142536-38F0D439-88D8-4740-A3B8-C999FE2C7262 Q41392869-1B8698E3-0AFE-4724-BC95-CB2E5854EF39 Q42769487-213706AB-5929-465F-BB6F-F2857E4C4FB8

P2860

A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxide.

http://www.wikidata.org/entity/Q35019853

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

A novel and potent inhibitor o ...... f cardiovascular nitric oxide.

@ast

A novel and potent inhibitor o ...... f cardiovascular nitric oxide.

@en

type

label

A novel and potent inhibitor o ...... f cardiovascular nitric oxide.

@ast

A novel and potent inhibitor o ...... f cardiovascular nitric oxide.

@en

prefLabel

A novel and potent inhibitor o ...... f cardiovascular nitric oxide.

@ast

A novel and potent inhibitor o ...... f cardiovascular nitric oxide.

@en

P1433

Q35019853-96D3587B-5AEA-4EBC-A266-AB23E0796D11

P1476

Q35019853-A017A319-64A1-45BF-A8DC-263F7E40446F

P2093

Q35019853-5E691F5D-025D-498A-95C4-B649E5F7A938

Q35019853-FA8B0BBB-DC70-499E-9F35-356CA37C904F

P2860

Q35019853-019FACF0-EBBC-4EC0-A235-5B1E2041520A

Q35019853-0796CE09-FB51-4A9D-AA16-BAD553A0FCA8

Q35019853-0E70034B-84EB-4137-BFFB-514450D38776

Q35019853-1327D71D-2144-4356-B576-426252EAA467

Q35019853-2263476C-FF24-4BEE-851E-9B7673BE369A

Q35019853-27470D44-EB14-4E97-B2E4-9A52AB48B7C1

Q35019853-2F484A2C-5D32-4218-94CD-FA67E184A5C0

Q35019853-30E2788A-BE95-48F3-A4B7-787B4FDFEA32

Q35019853-35AAEEFC-7430-4453-A432-7AA4DD7A912B

Q35019853-4700EEBA-439D-4C94-8F33-A348E2305C6D

P304

Q35019853-2CFB5770-95DF-4E23-996F-B5E4E208824B

P31

Q35019853-0D31CF0A-4B0B-463C-9B06-2371263F4A8E

P356

Q35019853-763A5F07-28B9-41A3-9998-2E9D6881FA84

P407

Q35019853-A20592DC-4A3C-41CB-86F6-7C03A05EE24D

P433

Q35019853-B4A6DBA8-DEA4-4596-B748-47C25BD22433

P478

Q35019853-C56E39D4-EE3D-4633-81AC-DE07509AB379

P50

Q35019853-5DC599C1-1A82-4CF5-A413-83BC5557C0CB

P577

Q35019853-81E98BCF-1E6A-4AC1-85EB-E94C049630C6

P5875

Q35019853-8B3350B5-E411-446F-9FBB-DF0F440E4994

P698

Q35019853-8F194E98-DBCE-4DEA-AB69-21ECAE8FC8DE

P932

Q35019853-31BF1AE2-0393-4EBA-9C37-8BFC256E68DF

P356

JPET.113.206847

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

A novel and potent inhibitor o ...... f cardiovascular nitric oxide.

@en

P2093

Daniel A Erlanson

http://www.w3.org/2001/XMLSchema#string

Yohannes T Ghebremariam

http://www.w3.org/2001/XMLSchema#string

P2860

Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide

Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury

Disruption of methylarginine metabolism impairs vascular homeostasis

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

CKIepsilon/delta-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging.

Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysis.

A continuous, fluorescent, high-throughput assay for human dimethylarginine dimethylaminohydrolase-1

P304

69-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.113.206847

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

348

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258054288

http://www.w3.org/2001/XMLSchema#string

P698

24135074

http://www.w3.org/2001/XMLSchema#string

P932

3868884

http://www.w3.org/2001/XMLSchema#string